In focus · trending topic

Dr Jerry Kanellos

7 stories · following the connections

Immuron CEO to Present at RedChip Global Online Growth Conference

By Nasdaq OMXApr 23, 2018, 10:57 PM UTC

Immuron Progresses Discussions with Institutional Funds

By Nasdaq OMXMar 13, 2018, 1:30 PM UTC

Immuron to Receive $2.16M R&D Tax Concession Refund

By Nasdaq OMXJan 24, 2018, 2:30 PM UTC

CEO to Present on US Investor TV Show and at Biotech Conference

By Nasdaq OMXJan 10, 2018, 2:04 PM UTC

Immuron to Present at RedChip’s Global Online Growth Conference

By Nasdaq OMXDec 6, 2017, 2:04 PM UTC

Immuron Successfully Completes NASH Phase II Clinical Study Milestone

By Nasdaq OMXNov 9, 2017, 2:01 PM UTC

Immuron Commences US Non-Deal Institutional Investor Roadshow

By Nasdaq OMXAug 15, 2017, 1:15 PM UTC